Global Lifestyle Archives | Page 21 of 455 | Be Korea-savvy

Archive by category Global Lifestyle

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love SAN DIEGO, Aug. 21, 2025 (Korea Bizwire) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced that its AirTouch™ N30i nasal cradle mask won two prestigious Red Dot Awards: Product [...]

Indonesia’s PP No. 28/2024 Threatens to Reinforce Cigarette Use Through Misguided Regulation

Indonesia’s PP No. 28/2024 Threatens to Reinforce Cigarette Use Through Misguided Regulation

JAKARTA, Indonesia, Aug. 21, 2025 (Korea Bizwire) — The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today warned that Indonesia’s proposed PP No. 28 Tahun 2024 risks undermining public health and entrenching cigarette dominance by restricting access to proven harm reduction alternatives. Indonesia is one of the world’s largest cigarette markets, where millions [...]

CGTN: Xizang’s development is a story of transformation and renewal

CGTN: Xizang’s development is a story of transformation and renewal

BEIJING, Aug. 19, 2025 (Korea Bizwire) — The story of today’s Xizang Autonomous Region can’t be told in isolation. The profound transformation, resilience and renewal that people see today are a stark departure from the dark legacy of serfdom. It is a testament to the power of development guided by people-centered governance. Once, at a [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Aug. 19, 2025 (Korea Bizwire) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Citi’s Biopharma Back [...]

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG Bahnhof Park 4 6340, Baar, Switzerland Media Relations Contact Madhu Marur madhu.marur@extrovis.com                                          Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy’s [...]

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. (Image from the company HQ) Collaboration strengthens Boehringer’s pipeline in Eye Health. Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. Melanocortin receptor agonists offer a promising, differentiated mechanism that targets key [...]

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (Korea Bizwire) — EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance (AMR). A Global Call to Action Antibiotic allergy mislabelling affects millions worldwide. Inaccurate labels lead to avoidance of first-line [...]

Bitget’s KCGI 2025 Wraps Up with Record-Breaking Participation and a $6M Prize Pool Across Global Challenges

Bitget’s KCGI 2025 Wraps Up with Record-Breaking Participation and a $6M Prize Pool Across Global Challenges

VICTORIA, Seychelles, Aug. 14, 2025 (Korea Bizwire) – Bitget, the world’s leading cryptocurrency exchange and Web3 company, has successfully concluded the King’s Cup Global Invitational (KCGI) 2025, marking one of the most competitive and community-driven events in the platform’s history. This year’s tournament drew 120,197 participants from around the world, forming a record 1,620 teams to battle across trading challenges for a [...]

Glasgow 2026 appoints Trivandi to deliver groundbreaking new format Commonwealth Games

Glasgow 2026 appoints Trivandi to deliver groundbreaking new format Commonwealth Games

GLASGOW, Scotland, Aug. 13, 2025 (Korea Bizwire) – In a move set to redefine the delivery of world-class sporting events, Glasgow 2026 Commonwealth Games has appointed Trivandi, a global leader in the planning, design and operational delivery of major events as Official Event Delivery Partner. The appointment brings together Glasgow’s celebrated reputation as a world-leading [...]

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

MILAN, Aug. 12, 2025 (Korea Bizwire) — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for AAVB-039, the company’s gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4. The Investigational [...]